Agenus Company Leadership
| AGEN Stock | USD 3.05 0.13 4.45% |
Agenus' insiders are aggressively buying. The analysis of the overall insider sentiment regarding Agenus Inc suggests that virtually all insiders are extremely bullish. Agenus employs about 316 people. The company is managed by 21 executives with a total tenure of roughly 48 years, averaging almost 2.0 years of service per executive, having 15.05 employees per reported executive.
| Garo Armen Chairman Founder, Executive Chairman, CEO and Chairman of Bus. and Devel. Advisory Committee |
Insider Sentiment 100
Aggressively Buying
Selling | Buying |
Latest Trades
| 2024-02-15 | Garo H Armen | Acquired 25000 @ 13 | View | ||
| 2023-10-16 | Agenus Inc | Acquired 21 @ 22 | View | ||
| 2023-10-12 | Agenus Inc | Acquired 158 @ 22 | View | ||
| 2023-10-04 | Agenus Inc | Acquired 750 @ 21.8 | View | ||
| 2023-08-28 | Agenus Inc | Acquired 640 @ 29 | View | ||
| 2023-08-24 | Agenus Inc | Acquired 8512 @ 30.8 | View | ||
| 2023-05-10 | Agenus Inc | Acquired 1103 @ 30.2 | View | ||
| 2023-05-05 | Agenus Inc | Acquired 5010 @ 19 | View | ||
| 2023-05-03 | Agenus Inc | Acquired 6434 @ 21.6 | View |
Monitoring Agenus' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. Agenus' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Agenus' future performance. Based on our forecasts, it is anticipated that Agenus will maintain a workforce of about 320 employees by March 2026.Agenus Management Team Effectiveness
The company has return on total asset (ROA) of (0.1666) % which means that it has lost $0.1666 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (12.7883) %, meaning that it created substantial loss on money invested by shareholders. Agenus' management efficiency ratios could be used to measure how well Agenus manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of February 2026, Return On Tangible Assets is likely to drop to -1.38. In addition to that, Return On Capital Employed is likely to grow to -27.03. At this time, Agenus' Asset Turnover is very stable compared to the past year.As of the 18th of February 2026, Common Stock Shares Outstanding is likely to grow to about 25.9 M, though Net Loss is likely to grow to (188.3 M). Agenus holds a total of 36.14 Million outstanding shares. Agenus Inc shows 7.59 percent of its outstanding shares held by insiders and 27.68 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Shares in Circulation | First Issued 2000-03-31 | Previous Quarter 28.1 M | Current Value 32.9 M | Avarage Shares Outstanding 5.1 M | Quarterly Volatility 7.1 M |
Agenus Workforce Comparison
Agenus Inc is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 1,258. Agenus totals roughly 316 in number of employees claiming about 25% of equities under Health Care industry.
The company has Profit Margin (PM) of (0.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16. Agenus Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Agenus insiders, such as employees or executives, is commonly permitted as long as it does not rely on Agenus' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Agenus insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2025-03-01 | 14.0 | 14 | 1 | 46,199 | 270.00 |
| 2024-06-01 | 9.5 | 19 | 2 | 369,480 | 37,500 |
| 2023-12-01 | 11.0 | 11 | 1 | 208,306 | 1,250 |
| 2023-03-01 | 13.0 | 13 | 1 | 3,615,727 | 37,500 |
| 2022-03-01 | 5.6667 | 17 | 3 | 3,338,235 | 146,179 |
| 2021-09-01 | 1.75 | 7 | 4 | 159,360 | 228,968 |
| 2021-06-01 | 7.25 | 29 | 4 | 4,000,664 | 93,501 |
| 2021-03-01 | 5.0 | 10 | 2 | 36,659 | 400,000 |
| 2020-12-01 | 4.0 | 24 | 6 | 3,896,864 | 248,299 |
| 2020-06-01 | 2.6 | 26 | 10 | 491,798 | 1,591,176 |
| 2019-12-01 | 3.0 | 15 | 5 | 2,935,347 | 547,715 |
| 2019-09-01 | 9.0 | 9 | 1 | 432,287 | 50,000 |
| 2019-06-01 | 23.0 | 23 | 1 | 3,835,742 | 15,000 |
| 2019-03-01 | 1.5 | 3 | 2 | 19,558 | 145,000 |
| 2018-12-01 | 6.0 | 6 | 1 | 254,714 | 6,500 |
| 2018-09-01 | 2.0 | 4 | 2 | 312,102 | 225,000 |
| 2018-06-01 | 9.5 | 19 | 2 | 2,014,523 | 140,974 |
| 2018-03-01 | 1.25 | 10 | 8 | 108,021 | 431,800 |
| 2017-12-01 | 2.1667 | 13 | 6 | 354,230 | 327,737 |
| 2017-09-01 | 1.0 | 1 | 1 | 4,375 | 150,000 |
| 2017-06-01 | 3.5 | 21 | 6 | 505,459 | 36,772 |
| 2017-03-01 | 2.5714 | 18 | 7 | 12,323,211 | 396,250 |
| 2016-12-01 | 0.6667 | 2 | 3 | 3,665 | 249,156 |
| 2016-06-01 | 4.0909 | 45 | 11 | 2,339,059 | 191,238 |
| 2016-03-01 | 4.0 | 4 | 1 | 207,960 | 150,000 |
| 2015-12-01 | 0.6 | 3 | 5 | 84,753 | 442,076 |
| 2015-09-01 | 11.0 | 11 | 1 | 294,649 | 60,500 |
| 2015-06-01 | 3.3333 | 10 | 3 | 1,851,367 | 1,113,210 |
| 2015-03-01 | 0.6667 | 12 | 18 | 410,544 | 2,504,655 |
| 2014-09-01 | 3.0 | 3 | 1 | 10,856 | 32,500 |
| 2014-06-01 | 5.0 | 15 | 3 | 302,931 | 394,846 |
| 2014-03-01 | 3.5 | 14 | 4 | 1,203,232 | 57,850 |
| 2013-06-01 | 8.0 | 16 | 2 | 491,771 | 32,500 |
| 2013-03-01 | 3.6667 | 11 | 3 | 20,596 | 3,987 |
| 2012-12-01 | 12.0 | 12 | 1 | 269,451 | 288.00 |
| 2012-09-01 | 2.8333 | 17 | 6 | 113,019 | 5,263 |
| 2012-06-01 | 3.1 | 31 | 10 | 869,769 | 92,168 |
| 2012-03-01 | 10.0 | 20 | 2 | 131,981 | 500,833 |
| 2011-12-01 | 0.56 | 14 | 25 | 36,428 | 61,208 |
| 2010-12-01 | 2.75 | 11 | 4 | 85,218 | 10,665 |
| 2010-09-01 | 2.4286 | 17 | 7 | 627,872 | 16,336 |
| 2010-06-01 | 8.6667 | 26 | 3 | 306,752 | 8,615 |
| 2010-03-01 | 3.4286 | 24 | 7 | 1,993,296 | 472,688 |
| 2009-09-01 | 0.6176 | 21 | 34 | 1,440,370 | 1,172,713 |
| 2009-06-01 | 15.0 | 15 | 1 | 592,099 | 171,861 |
| 2009-03-01 | 4.1667 | 25 | 6 | 812,910 | 111,046 |
| 2008-09-01 | 5.5 | 22 | 4 | 750,154 | 3,365,181 |
| 2008-06-01 | 6.5 | 13 | 2 | 147,701 | 25,000 |
| 2008-03-01 | 6.6667 | 20 | 3 | 2,059,562 | 28,127 |
| 2007-09-01 | 2.0 | 6 | 3 | 585,895 | 107,267 |
| 2007-06-01 | 11.0 | 11 | 1 | 136,970 | 0.00 |
| 2007-03-01 | 11.0 | 22 | 2 | 408,129 | 70,000 |
| 2006-12-01 | 0.8 | 4 | 5 | 18,267 | 159,500 |
| 2006-03-01 | 2.75 | 11 | 4 | 331,939 | 174,830 |
| 2005-12-01 | 5.0 | 5 | 1 | 6,522 | 25,000 |
| 2005-09-01 | 5.0 | 5 | 1 | 5,480 | 125,000 |
| 2005-03-01 | 8.0 | 8 | 1 | 438,470 | 6,800 |
| 2004-09-01 | 1.0 | 1 | 1 | 25,000 | 20,000 |
| 2004-03-01 | 2.0 | 4 | 2 | 375,000 | 65,000 |
Agenus Notable Stakeholders
An Agenus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Agenus often face trade-offs trying to please all of them. Agenus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Agenus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Garo Armen | Founder, Executive Chairman, CEO and Chairman of Bus. and Devel. Advisory Committee | Profile | |
| Jennifer Buell | Director Therapeutics | Profile | |
| Christine Klaskin | Principal Accounting Officer and VP of Fin. | Profile | |
| Julie DeSander | Chief Officer | Profile | |
| Alfred Dadson | Chief Officer | Profile | |
| Eric Humes | Chief Officer | Profile | |
| Regina Grebla | VP Communications | Profile | |
| Dr MBA | Chief Officer | Profile | |
| John Castle | Head Bioinformatics | Profile | |
| Zack Armen | Head Development | Profile | |
| Dhan Chand | Scientific Discovery | Profile | |
| Divya Vasudevan | Senior Relations | Profile | |
| Nils MD | Chief Officer | Profile | |
| Tracy Clemente | Chief Officer | Profile | |
| Burcu Yigit | Scientist II | Profile | |
| Austin Charette | Principal Officer | Profile | |
| Todd MD | Member Advisor | Profile | |
| Craig Winter | Chief Officer | Profile | |
| Robin JD | Chief Officer | Profile | |
| Stephanie Fagan | Chief Officer | Profile | |
| Stefanie PernaNacar | Chief Officer | Profile |
About Agenus Management Performance
The success or failure of an entity such as Agenus Inc often depends on how effective the management is. Agenus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Agenus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Agenus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.31) | (1.38) | |
| Return On Capital Employed | (28.45) | (27.03) | |
| Return On Assets | (1.15) | (1.21) | |
| Return On Equity | 0.63 | 0.61 |
Agenus Workforce Analysis
Traditionally, organizations such as Agenus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Agenus within its industry.Agenus Manpower Efficiency
Return on Agenus Manpower
| Revenue Per Employee | 327.4K | |
| Revenue Per Executive | 4.9M | |
| Net Loss Per Employee | 735K | |
| Net Loss Per Executive | 11.1M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Will Biotechnology sector continue expanding? Could Agenus diversify its offerings? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Agenus data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.57) | Revenue Per Share | Quarterly Revenue Growth 0.204 | Return On Assets | Return On Equity |
Investors evaluate Agenus Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Agenus' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Agenus' market price to deviate significantly from intrinsic value.
Understanding that Agenus' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Agenus represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Agenus' market price signifies the transaction level at which participants voluntarily complete trades.